Percutaneous cholecystostomy in elderly patients with acute cholecystitis: a systematic review and meta-analysis.
Alfonso TerroneMarcello Di MartinoSara SaeidiChiara RanucciSalomone Di SaverioAntonio GiulianiPublished in: Updates in surgery (2024)
Percutaneous cholecystostomy (PC) is often preferred over early cholecystectomy (EC) for elderly patients presenting with acute cholecystitis (AC). However, there is a lack of solid data on this issue. Following the PRISMA guidelines, we searched the Medline and Web of Science databases for reports published before December 2022. Studies that assessed elderly patients (aged 65 years and older) with AC treated using PC, in comparison with those treated with EC, were included. Outcomes analyzed were perioperative outcomes and readmissions. The literature search yielded 3279 records, from which 7 papers (1208 patients) met the inclusion criteria. No clinical trials were identified. Patients undergoing PC comprised a higher percentage of cases with ASA III or IV status (OR 3.49, 95%CI 1.59-7.69, p = 0.009) and individuals with moderate to severe AC (OR 1.78, 95%CI 1.00-3.16, p = 0.05). No significant differences were observed in terms of mortality and morbidity. However, patients in the PC groups exhibited a higher rate of readmissions (OR 3.77, 95%CI 2.35-6.05, p < 0.001) and a greater incidence of persistent or recurrent gallstone disease (OR 12.60, 95%CI 3.09-51.38, p < 0.001). Elderly patients selected for PC, displayed greater frailty and more severe AC, but did not exhibit increased post-interventional morbidity and mortality compared to those undergoing EC. Despite their inferior life expectancy, they still presented a greater likelihood of persistent or recurrent disease compared to the control group.
Keyphrases
- end stage renal disease
- patients undergoing
- newly diagnosed
- clinical trial
- ejection fraction
- community dwelling
- chronic kidney disease
- risk factors
- systematic review
- public health
- middle aged
- type diabetes
- prognostic factors
- randomized controlled trial
- peritoneal dialysis
- emergency department
- cardiovascular disease
- drug induced
- liver failure
- physical activity
- clinical practice
- respiratory failure
- electronic health record
- acute kidney injury
- radiofrequency ablation
- study protocol
- phase ii
- case control
- adverse drug
- clinical evaluation